Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
4basebio Plc | 4BB | May 31, 2024 | 1 419.00 | +1.87 |
Avacta Group Plc | AVCT | May 31, 2024 | 42.62 | -0.88 |
Bioventix Plc | BVXP | May 31, 2024 | 4 300.00 | 0.00 |
Destiny Pharma | DEST | May 31, 2024 | 15.75 | -0.54 |
Diaceutics Plc | DXRX | May 31, 2024 | 134.30 | -0.15 |
E-Therapeutics Plc | ETX | May 31, 2024 | 9.00 | 0.00 |
Evgen Pharma Plc | EVG | May 31, 2024 | 0.82 | 0.00 |
Fusion Antibodies Plc | FAB | May 31, 2024 | 3.80 | -0.31 |
Futura Medical | FUM | May 31, 2024 | 37.46 | -0.21 |
Hemogenyx Pharmaceuticals Plc | HEMO | May 31, 2024 | 1.47 | -3.24 |
HUTCHMED (China) Limited | HCM | May 31, 2024 | 296.97 | -0.35 |
Immupharma Plc | IMM | May 31, 2024 | 2.12 | +2.71 |
Ixico Plc | IXI | May 31, 2024 | 6.75 | +0.07 |
NetScientific plc | NSCI | May 31, 2024 | 67.34 | -0.04 |
Nuformix plc | NFX | May 31, 2024 | 0.21 | +5.58 |
Oncimmune Holdings plc | ONC | May 31, 2024 | 19.24 | -19.02 |
OptiBiotix Health plc | OPTI | May 31, 2024 | 18.88 | 0.00 |
Ovoca Bio Plc | OVB | May 31, 2024 | 0.96 | +2.00 |
Oxford BioDynamics plc | OBD | May 31, 2024 | 7.86 | -1.49 |
Oxford Biomedica | OXB | May 31, 2024 | 331.00 | +3.28 |
Physiomics | PYC | May 31, 2024 | 1.36 | +10.57 |
PureTech Health Plc | PRTC | May 31, 2024 | 234.00 | +0.65 |
Reneuron Group | RENE | May 31, 2024 | 3.27 | 0.00 |
Sareum Holdings Plc | SAR | May 31, 2024 | 44.00 | +5.26 |
Scancell Hldgs Plc | SCLP | May 31, 2024 | 9.85 | +0.23 |
SkinBioTherapeutics Plc | SBTX | May 31, 2024 | 9.36 | -0.46 |
Synairgen | SNG | May 31, 2024 | 6.74 | -1.38 |
Tissue Regenix Group Plc | TRX | May 31, 2024 | 69.82 | +5.45 |
Valirx Plc | VAL | May 31, 2024 | 2.94 | +0.88 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.